Company intelligence / Profile preview

Dragonfly 44 Capital

New York City, New York, United Statesdragonfly44.capital ↗

Ownership: Private
Development stage: Other

Overview

Dragonfly 44 Capital provides financial and strategic consulting services to companies in neuroscience-related fields such as neuropsychiatry, mental healthcare, psychedelics, longevity, and wellness. The firm specializes in mergers and acquisitions support, fundraising guidance, and tailored business development for innovative companies advancing neurotherapeutics, diagnostics, healthtech, and neurotech.

Industry: Consulting

Partnerships

Not specified publicly; works with clients across the neuroscience sector

Beyond the preview

Go deeper on Dragonfly 44 Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dragonfly 44 Capital.

Explore the full profile